Vesting of Securities for Directors, Company Secretary and Prescribed Officers of the Company ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) ("Aspen Holdings") Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 ("Aspen" or "the Company") VESTING OF SECURITIES FOR DIRECTORS, COMPANY SECRETARY AND PRESCRIBED OFFICERS OF THE COMPANY In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of the following information: Deferred bonus shares, awarded in 2020 in respect of the Aspen South African Management Deferred Incentive Scheme, have vested and have been delivered to the undermentioned directors, company secretary, and prescribed officers of the Company. Director : Stephen Bradley Saad Company : Aspen Pharmacare Holdings Limited Date of transaction : 20 October 2023 Shares to be delivered – off market : 35 862 Price on acceptance : R 164.01 Value of shares to be delivered : R 5 881 726.62 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Not applicable – no dealing by director involved Director : Sean Matthew Capazorio Company : Aspen Pharmacare Holdings Limited Date of transaction : 20 October 2023 Shares to be delivered – off market : 17 507 Price on acceptance : R 164.01 Value of shares to be delivered : R 2 871 323.07 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Not applicable – no dealing by director involved Name : Michael Guy Attridge – Prescribed Officer Company : Aspen Pharmacare Holdings Limited Date of transaction : 20 October 2023 Shares to be delivered – off market : 29 647 Price on acceptance : R 164.01 Value of shares to be delivered : R 4 862 404.47 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Not applicable – no dealing by director involved Name : Reginald Haman – Prescribed Officer & Company Secretary Company : Aspen Pharmacare Holdings Limited Date of transaction : 20 October 2023 Shares to be delivered – off market : 15 442 Price on acceptance : R 164.01 Value of shares to be delivered : R 2 532 642.42 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Not applicable – no dealing by director involved Name : Lorraine Angela Hill – Prescribed Officer Company : Aspen Pharmacare Holdings Limited Date of transaction : 20 October 2023 Shares to be delivered – off market : 25 141 Price on acceptance : R 164.01 Value of shares to be delivered : R 4 123 375.41 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Not applicable – no dealing by director involved Name : Zizipho Mmango – Prescribed Officer Company : Aspen Pharmacare Holdings Limited Date of transaction : 20 October 2023 Shares to be delivered – off market : 2 681 Price on acceptance : R164.01 Value of shares to be delivered : R 439 710.81 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Not applicable – no dealing by director involved Durban 23 October 2023 Sponsor Investec Bank Limited Date: 23-10-2023 03:50:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.